Videos

Featured

View from the Thoraxcenter: ESC Congress 25 Preview

Joost Daemen, Nicolas M Van Mieghem

Watch time: 36m 33s
ESC 25: TRISCEND II Trial: TTVR Outcomes by Baseline TR Severity

Philipp Lurz

Watch time: 4m 15s
TTE and TEE in the New TAVR Era with Dr Victoria Delgado

Victoria Delgado

Watch time: 16m 27s
NY Valves 25: The Tri-QOL Study

Watch time: 5m 58s
EuroPCR 25: The TRICURE EU Study

Julien Dreyfus

Watch time: 4m 9s
SCAI 25: Insights from the TRITAVI Registry

Francesco Pelliccia

Watch time: 11m 23s
NY Valves 25: Lifetime Management in TAVR Patients

Tanush Gupta

Watch time: 12m 2s
TCT Middle East 25: Minimally Invasive Surgery

Rania Hammami, Uthman Aluthman

Watch time: 5m 1s
EuroPCR 25: BIOADAPTOR RCT 3Y Outcomes

Shigeru Saito

Watch time: 2m 29s
EHRA 25: The SwissTAVI Registry

Watch time: 3m 9s

Broadcast

Intervention
Transcatheter Interventions Online 2025 - Day One

Nicolas M Van Mieghem, David Hildick-Smith, Roxana Mehran, et al

PART 1: RE-DUAL PCI – Switching Of NOACs

Jur ten Berg

Watch time: 12m 32s
PART 2: RE-DUAL PCI – Diabetes sub-group analysis

Christopher P Cannon

Watch time: 11m 8s

Jur ten Berg, Christopher P Cannon

Watch time: 23m 40s (2 videos)

Broadcast

Intervention

Vascular Disease and Surgery
Percutaneous Closure of Paravalvular Leaks

Ignacio Cruz, David Northridge, Martin Swaans, et al

Watch time: 57m 54s

Andrew SP Sharp, Atul Pathak, Roland E Schmieder, et al

Watch time: 1h 29m 27s (3 videos)

Broadcast

Intervention

MI/ACS
Multi Vessel Disease in STEMI

Pim Tonino, Jacques Monsegu

Watch time: 35m 13s

Broadcast

Intervention

Vascular Disease and Surgery
TAVR in Bicuspid Disease

Nicolas M Van Mieghem, Basel Ramlawi, Didier Tchétché, et al

Watch time: 1h 4m 17s
HRS 2020: Primary Outcome Evaluation of The PINNACLE FLX Study

Watch time: 9m 6s
PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 16m 18s
PART 2: Evolution of the data

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 25m 57s
PART 3: Practical implementation and current guidelines

Jan Steffel, Jur ten Berg, Stefan H Hohnloser, et al

Watch time: 22m 30s

Jan Steffel, Jur ten Berg, Stefan H Hohnloser

Watch time: 1h 4m 45s (3 videos)
CRT 2020: The AIDA trial: 2-year outcomes

Watch time: 3m 7s
ACC 2020: PRONOMOS Trial - Rivaroxaban Versus Enoxaparin

Watch time: 8m 41s
ACC 2020: Updates from the PARTNER 3 Trial

Michael J Mack

Watch time: 7m 10s
ACC 2020: Results from the Global EXPAND Study

D Scott Lim

Watch time: 11m 10s